Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with private insurance
Trial 3 Results at Week 26 in a Trial of RYBELSUS Compared to Sitagliptin 100 mg Once Daily in Adult Patients with Type 2 Diabetes Mellitus in Combination with Metformin or Metformin with Sulfonylurea a The intent-to-treat population includes all randomized patients
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding genetic predispositions in metabolic and thyroid-related pathways, such as variants in FTO and MC4R genes that influence weight regulation and thyroid hormone metabolism
Beneficiaries can expect additional guidance and information as the program begins, including details on participating medications and enrollment processes
US$ 27.68
US$ 26.42
US$ 28.14
US$ 29.87
US$ 21.56
US$ 29.07
